Show simple item record

dc.contributor.advisorLeslie, Christina
dc.contributor.authorSingh, Irtisha
dc.date.accessioned2019-03-26T19:08:08Z
dc.date.available2019-03-27T06:01:00Z
dc.date.issued2017
dc.identifier.urihttps://hdl.handle.net/1813/64737
dc.description.abstractAlternative cleavage and polyadenylation (ApA) is most often viewed as the selection of alternative pA signals in the 3' UTR, generating 3' UTR isoforms that code for the same protein. However, ApA events can also occur in introns, generating either non-coding transcripts or truncated protein-coding isoforms due to the loss of C-terminal protein domains, leading to diversification of the proteome. Due to lack of a study that characterizes the intronic polyadenylation isoforms on a genome wide level, we decided to investigate the cell type specificity and potential functional consequences of isoforms generated by intronic ApA. We therefore carried out an analysis of 3'-seq and RNA-seq profiles from chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) samples as compared to mature human B cells (naïve and CD5+) and plasma cells, respectively, together with our previous 3'-seq atlas generated from a wide variety of tissues and cell lines. We found that in more than 20 percent of human genes, intronic polyadenylation (IpA) sites are used to generate alternative 3' ends. This analysis shows that IpA is a normal and regulated process, most widely used in immune cells. IpA events are enriched near the start of the transcription unit, yielding non-coding transcripts or messages with minimal coding sequence (CDS). The expression of truncated mRNAs contributes to proteome diversity in normal cells. However, we found that cancer cells can take advantage of this mechanism to mimic genetic mutations. Many genes with truncating mutations in CLL express IpA isoforms. Cancer cells lacking genetic aberrations can disrupt IpA to generate truncated mRNAs. These IpA isoforms potentially have similar functional outcome as truncating mutations. In this study we unravel a new mechanism by which cancer cells can contribute to tumorigenesis.
dc.language.isoen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject3'-seq
dc.subject3' UTR
dc.subjectchronic lymphocytic leukemia
dc.subjectintronic
dc.subjectmultiple myeloma
dc.subjectpolyadenylation
dc.titleCharacterization Of Intronic Polyadenylation Isoforms In Normal Human Cells And B Cell Malignancies
dc.typedissertation or thesis
thesis.degree.disciplinePhysiology, Biophysics & Systems Biology
thesis.degree.grantorWeill Cornell Graduate School of Medical Sciences
thesis.degree.levelDoctor of Philosophy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

Statistics